Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion. [electronic resource]
Producer: 20061003Description: 273-8 p. digitalISSN:- 0949-2321
- Acute Disease
- Adult
- Anti-HIV Agents -- therapeutic use
- Antiretroviral Therapy, Highly Active -- methods
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- HIV Seropositivity -- drug therapy
- HIV-1 -- genetics
- Histocompatibility Testing
- Humans
- Lamivudine -- therapeutic use
- Lopinavir
- Male
- Pyrimidinones -- therapeutic use
- RNA, Viral -- genetics
- Retrospective Studies
- Stavudine -- therapeutic use
- Treatment Outcome
- Zidovudine -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.